Putnam Investments’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
Putnam Investments's AMED Position: Q2 2021 in Review
Putnam Investments sold out of Amedisys (AMED) in Q2 2021, closing a stake of 61,963 shares — an estimated $16.4M sold.
Putnam Investments first reported a position in AMED in Q2 2013 and held it in 15 quarters. The position peaked at $24.2M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.
- Putnam Investments reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
- Putnam Investments sold 61,963 Amedisys shares in Q2 2021, an estimated $16.4M.
- Putnam Investments first reported a position in Amedisys in Q2 2013 and held it in 15 quarters.
- Putnam Investments's Amedisys position peaked at $24.2M in Q4 2020.
- 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.
Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.